A researcher from the University of Queensland and a leading researcher at Botanix Pharmaceuticals Mark Blaskovich spoke at a conference of the American Society for Microbiology about a new, potentially revolutionary drug. The composition with working index BTX 1801 is based on cannabidiol and is intended to fight bacteria. Moreover, there is evidence that it can destroy antibiotic-resistant strains.
Botanix Pharmaceuticals reports the extraordinary effectiveness of BTX 1801 in killing bacteria. And the drug acts quickly, destroying the entire population of harmful microbes in just a few hours. And bacteria could not develop immunity to it even after numerous contacts. True, human trials have not yet been conducted, but another cannabidiol-based drug, BTX 1503, has already been successfully used in the treatment of acne and acne.
A general analysis of the information presented allows us to conclude that the healing potential of cannabidiol applies only to gram-positive bacteria, but not gram-negative ones. That is, he still cannot become a panacea and a new effective analogue of antibiotics. But even the benefits that can be obtained from it make growing marijuana for medical purposes for the production of cannabidiol even more reasonable and beneficial than before.
It is important to note that the information is provided on the basis of information from Botanix Pharmaceuticals, without publication in scientific journals and peer review. And the exaggeration of the properties of cannabidiol, as well as medicinal preparations from it, cannot be ruled out.